Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Analyst Ratings

Deutsche Bank Maintains Buy on Aperam S.A. (APEMY) Feb 2026

February 10, 2026
4 min read
Share with:

On February 9, 2026, Deutsche Bank maintained a Buy on Aperam S.A. (APEMY) and raised the price target to EUR 62 from EUR 42. This action kept the firm’s positive stance while signaling higher confidence in Aperam’s earnings power. The move is a core input for investors watching steel and stainless-steel exposure and the broader metals sector.

APEMY analyst rating: Deutsche Bank action and details

Deutsche Bank issued its note on Feb 09, 2026 at 12:38 PM, maintaining a Buy rating and lifting its price target to EUR 62 from EUR 42. The research was reported by TheFly and is linked to Aperam’s recent operational outlook and margin trends. source

Sponsored

Market reaction and price context for APEMY analyst rating

At the time of the note the posted price was listed as N/A with zero percentage change reported. Market-cap stands at $3,519,766,358 which frames Aperam as a mid-cap European steel player. Short-term stock moves may lag analyst commentary if liquidity or macro drivers dominate trading.

What the Deutsche Bank change means for investors

Maintaining a Buy while raising a price target signals expectation of stronger earnings or multiple expansion. Investors should read this as confidence in Aperam’s margins, pricing power, or capital allocation. For traders, the price-target gap implies potential upside of roughly the percentage between the current market price and EUR 62.

Analyst coverage history and other firms

Deutsche Bank is the only recent firm that changed a rating on Feb 09, 2026. Other houses, including JPMorgan, have publicly covered Aperam with Buy stances in short-term listings. Historical coverage shows consistent analyst interest tied to cyclical demand and regional trade policy shifts.

Meyka grade and how we incorporate ratings

Meyka AI rates APEMY with a grade of B. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors. Use the grade with other research inputs from our platform at Meyka APEMY page.

Near-term outlook, risks, and implications for strategy

Key near-term risks include weaker global steel demand and import dumping pressure from Asia. Management notes ongoing reviews and exposure to construction demand in Germany and Brazil. Investors should balance Deutsche Bank’s upgraded price target against those macro and policy risks before changing portfolio weightings.

Final Thoughts

Deutsche Bank’s Feb 09, 2026 decision to maintain a Buy and lift the Aperam price target to EUR 62 reinforces a bullish analyst view while keeping the stock on investor radars. The action supports the case that Aperam can expand margins or re-rate its earnings multiple. We connect this rating to Aperam’s market-cap of $3,519,766,358 and ongoing coverage by other firms. For investors, the change means a clearer quantified upside target to weigh against sector cyclicality and trade risks. Use this APEMY analyst rating alongside company results, macro data, and the Meyka AI grade when considering allocation. Remember, Meyka grades are not guarantees and we are not financial advisors.

FAQs

What exactly changed in the latest APEMY analyst rating?

On Feb 09, 2026, Deutsche Bank maintained a Buy on Aperam and raised the price target to EUR 62 from EUR 42. The update preserved the positive rating while signaling stronger expected earnings or valuation upside.

How should investors use the updated APEMY price target?

Treat the EUR 62 target as one analyst view. Combine it with Aperam’s fundamentals, sector trends, and the Meyka grade of B. Use the target to size positions relative to your risk tolerance and portfolio goals.

Does the APEMY analyst rating change affect company fundamentals?

No. Analyst ratings reflect expected performance and valuation, not direct changes to Aperam’s operations. A maintained Buy with a higher target reflects revised expectations for revenue, margins, or multiples based on available data.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
~15% average open rate and growing
Trusted by 10,000+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)